Key findings were:
• The greater the degree of inflammation, as measured by elevated CRP levels, the greater the signal of efficacy of remestemcel-L treatment in improving moderate to severe lung disease
• Significant improvements were observed in each of the pre-specified endpoints tested, forced expiratory volume, forced vital capacity, and the distance walked in the six-minute walk test (all p <0.01), with maximal effects on all parameters seen at four months
• In patients with the highest level of CRP (>4mg/L), those who received remestemcel-L were able to walk 55 meters further than placebo-treated patients in the six-minute walk test at four months (p=0.004); the six-minute walk test is a major independent predictor of mortality in COPD2
• The dose administered was well tolerated with no infusion-related toxicity and no identified safety concerns. Mesoblast Chief Medical Officer Dr Fred Grossman said: “
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease
Ann: Remestemcel-L Improves Outcomes in Inflammatory Lung Disease, page-4
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.11 |
Change
0.000(0.00%) |
Mkt cap ! $1.267B |
Open | High | Low | Value | Volume |
$1.13 | $1.13 | $1.06 | $12.24M | 11.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 32118 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 21178 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32118 | 1.105 |
1 | 5000 | 1.100 |
3 | 15300 | 1.090 |
4 | 57493 | 1.085 |
3 | 29560 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.115 | 21178 | 2 |
1.120 | 10880 | 3 |
1.125 | 63186 | 5 |
1.130 | 120135 | 5 |
1.135 | 29000 | 2 |
Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.10 |
  |
Change
0.000 ( 2.07 %) |
|||
Open | High | Low | Volume | ||
$1.12 | $1.12 | $1.06 | 1826006 | ||
Last updated 15.59pm 31/05/2024 ? |
Featured News
MSB (ASX) Chart |